Wei Tian, PhD

Director Formulation at Lonza

Wei Tian is an experienced pharmaceutical development professional and has achieved market authorization of several generic and NCE products in the EU and US. Many of these products were approved through the 505(b)2 application route, through reformulation and dosage changes.


Title: Lipid based formulation for enhanced bioavailability

  • Fundamental of lipid based formulation: introduction to lipid chemistry and its absorption, leading to the rational design of lipid based formulations
  • Formulation design and in-vitro assessment
  • Case study of a lipid based formulation